This document discusses trends in genetic modification and the legal issues surrounding it. It begins by defining genetic engineering and outlining some current trends, including integrating genomic data into clinical workflows, genetic screening, and pharmacogenomics. It then examines the legal and ethical ramifications of genetic modification, noting a lack of clear legislation. Emerging issues include ownership, rights, and health insurance questions. The document advocates applying the precautionary principle to proceed cautiously with genetic modification until safety can be demonstrated.
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Scott Schweikart, Senior Research Associate, Council on Ethical and Judicial Affairs, American Medical Association and Legal Editor, AMA Journal of Ethics - Human Gene Editing: An Ethical Analysis and Arguments for Regulatory Guidance at Both the National and Global Levels
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...SC CTSI at USC and CHLA
In her 60-minute presentation, Professor Charo addressed Ethical Challenges in Trials of Human Genome Editing and Gene Therapy, as gene therapy and genome editing clinical trials involve ethical challenges not always found in other areas of research.
These slides discusses on cellular and gene therapy: the use of cells and genes to treat disease. These therapies can be effective on a wide range of previously untreated diseases, such as hematological, ocular, neurodegenerative diseases, and several types of cancers.
INTRODUCTION
DNA VACCINES
GENE THERAPY
TIME LINE OF DEVELOPING GENE THERAPY
GENE THERAPY STRATEGIES
TECHNOLOGY OF CLASSICAL GENE THERAPY
PRINCIPLES OF GENE TRANSFER
VECTORS
VIRAL VECTORS
NON-VIRAL VECTORS
APPLICATIONS OF GENE THERAPY
ETHICAL IMPLICATIONS
THE FUTURE
CONCLUSION
REFERENCES
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Scott Schweikart, Senior Research Associate, Council on Ethical and Judicial Affairs, American Medical Association and Legal Editor, AMA Journal of Ethics - Human Gene Editing: An Ethical Analysis and Arguments for Regulatory Guidance at Both the National and Global Levels
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
Research Ethics Forum: Ethical Challenges in Trials of Human Genome Editing a...SC CTSI at USC and CHLA
In her 60-minute presentation, Professor Charo addressed Ethical Challenges in Trials of Human Genome Editing and Gene Therapy, as gene therapy and genome editing clinical trials involve ethical challenges not always found in other areas of research.
These slides discusses on cellular and gene therapy: the use of cells and genes to treat disease. These therapies can be effective on a wide range of previously untreated diseases, such as hematological, ocular, neurodegenerative diseases, and several types of cancers.
INTRODUCTION
DNA VACCINES
GENE THERAPY
TIME LINE OF DEVELOPING GENE THERAPY
GENE THERAPY STRATEGIES
TECHNOLOGY OF CLASSICAL GENE THERAPY
PRINCIPLES OF GENE TRANSFER
VECTORS
VIRAL VECTORS
NON-VIRAL VECTORS
APPLICATIONS OF GENE THERAPY
ETHICAL IMPLICATIONS
THE FUTURE
CONCLUSION
REFERENCES
Gene therapy advanced treatments for a new era aranca special reportAranca
Aranca's Report on Gene Therapy - a promising tool for Cancer, Parkinson's, HIV, severe combined immuno-deficiencies, hemophilia etc. In this report, you will discover the challenges associated with Gene Therapy as well as its expected future.
Gene therapy involves the insertion of a functioning gene into cells to correct a cellular dysfunction
KEY WORDS : GENETICS, MUTATION , GENETIC ENGINEERING.
Forum on Personalized Medicine: Challenges for the next decadeJoaquin Dopazo
Bioinformatics and Big Data in the era of Personalized Medicine
10th Anniversary Instituto Roche Forum on Personalized Medicine: Challenges for the next decade.
Santiago de Compostela (Spain), September 25th 2014
January 26, 2018
In the United States, two major federal laws apply to vertebrate animals used in laboratory research. The first of these two statutes, the Animal Welfare Act (AWA, under the US Department of Agriculture), celebrated its fiftieth anniversary in 2016. The second statute, the Health Research Extension Act of 1985 (also referred to as the Public Health Services Act, or PHS Act), which is similar to the AWA, applies specifically to work funded by the US Public Health Service (i.e., agencies under the Department of Health and Human Services). Understanding laboratory animal law is necessary and fundamental for all researchers relying on results from animal research, laboratory animal veterinarians, institutional officials, Institutional Animal Care and Use Committee (IACUC) members and veterinarians in training. They require familiarity with both the scope and particulars of these laws. Different parties interested in or impacted by laboratory animal laws can have significantly different perspectives about the scope or efficiency of the regulations or their implementation.
The Roundtable on Science and Welfare in Laboratory Animal Use of the Institute for Laboratory Animal Research, the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics, and the Animal Law and Policy Program of Harvard Law School convened this pre-workshop webcast and a workshop to discuss the future of federal laboratory animal law in the United States.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/future-directions-for-laboratory-animal-law-in-the-united-states
Gene therapy is a new tool used in combating different diseases. The majority of gene therapy clinical trials are focused on cancer and so it was no coincidence that the first commercial treatment in 2003 was for neoplasia. Currently there are a wide variety of gene therapy proposals involving a large number of anti tumour molecular mechanisms that will conceivably pave the way for highly effective a treatment options. Despite the significant advances that how been made in gene therapy in the fight against cancer, its efficacy,safety and commercial availability are still limited. Ms. Chetana D. Patil | Ms. Siddhi Chavan | Mr. Ritesh Kadam "Gene Therapy for Cancer Treatment" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-5 , August 2019, URL: https://www.ijtsrd.com/papers/ijtsrd26537.pdfPaper URL: https://www.ijtsrd.com/pharmacy/biotechnology-/26537/gene-therapy-for-cancer-treatment/ms-chetana-d-patil
Nutrigenomics is the science that examines the response of individuals to food compounds using post-genomic and related technologies (e.g. genomics, transcriptomics, proteomics, metabol/nomic etc.). The long-term aim of nutrigenomics is to understand how the whole body responds to real foods using an integrated approach termed 'systems biology'. The huge advantage in this approach is that the studies can examine people (i.e. populations, sub-populations - based on genes or disease - and individuals), food, life-stage and life-style without preconceived ideas.
Steve Rozen's keynote talk at IEEE CIBCB 2016
Big Genome Data Sheds Light on Cancer Causes
Steven G. Rozen, PhD
Professor, Cancer & Stem Cell Programme, Duke-NUS Medical School, Singapore
Director, Duke-NUS Centre for Computational Biology
The last eight years have see a revolution in the availability of DNA sequencing data. This revolution has been driven by costs that have plummeted from US$ 10 million per human genome in 2008 to US $1,200 today. Abundant sequencing data brings with it a previously unimaginable range of research possibilities in all areas of biomedical research. Naturally, these research possibilities make heavy demands on computation and data storage, because costs of sequencing are falling much faster than Moore's law. In this talk I will present a high level overview of these computational demands. I will then go into detail on a few of the cancer-related big data projects my lab is working on. One of these is "mutation signature analysis", which has important applications in cancer prevention and epidemiology and in research into the fundamental processes by which cancers arise. One example of the importance of this approach is the recent finding that a highly mutagenic herbal remedy is implicated in many more geographical regions and types of cancer than suspected a few years ago.
Gene is the basic physical unit of inheritance that passed information from parents to offspring. Genes are arranged, one after another, on structure called chromosome.
A gene is region of DNA that encodes function and chromosome consist of long DNA strands containing many genes.
A human chromosome can have up to 500 million base pair of DNA with thousands of genes.
Technique responsible for correcting the defective genes responsible for disease development is called Gene Therapy
Final presentation for BIOL405, NSC, Spring 2014. Presented by Kevin Hugins and Duy-Khiem Chanh Pham. This presentation addressed the use of Chimeric Antigen Receptors for gene therapy for cancer. Gene therapy was first conceptualized to alter debilitating fates of genetic diseases. Gene therapy technology can help introduce new functional DNA to replace mutated genes. The idea first arose in 1972 when Friedmann and Roblin authored a paper, “Gene therapy for human genetic disease?”, demonstrating that exogenous DNA can be taken up by mammalian cells (1). They proposed that the same procedure could be done on humans to correct genetic defects by introducing therapeutic DNA. Currently, genetic modification of T lymphocytes has been the major area of research for treating malignant tumors. This technique seeks to create chimeric antigen receptor (CAR) in T cells by genetically modifying them in vitro and reintroduce them back into blood circulation. The T cells are unique to every patient and the chimeric antigen receptors are unique to the tumor that it is targeting.
Crowdsourcing applied to knowledge management in translational research: the ...SC CTSI at USC and CHLA
Date: November 8th, 2018
Speaker: Andrew Su, PhD, Professor, Department of Integrative, Structural and Computational Biology, The Scripps Research Institute
Overview: Crowdsourcing involves the engagement of large communities of individuals to collaboratively accomplish tasks at massive scale. These tasks could be online or offline, paid or for free. But how can crowdsourcing science help your research? This webinar will describe two crowdsourcing projects for translational research, both of which aim to better organize biomedical information so that it can be more easily accessed, integrated, and queried:
First, the goal of the Gene Wiki project is to create a community-maintained knowledge base of all relationships between biological entities, including genes, diseases, drugs, pathways, and variants. This project draws on the collective efforts of informatics researchers from a wide range of disciplines, including bioinformatics, cheminformatics, and medical informatics.
Second, the Mark2Cure project partners with the citizen scientist community to extract structured content from biomedical abstracts with an emphasis on rare disease. Although citizen scientists do not have any specialized expertise, after receiving proper training, Mark2Cure has shown that in aggregate they perform bio-curation at an accuracy comparable to professional scientists.
Genetic Engineering in AgricultureFew topics in agriculture are .docxhanneloremccaffery
Genetic Engineering in Agriculture
Few topics in agriculture are more polarizing than genetic engineering (GE), the process of manipulating an organism s genetic material—usually using genes from other species—in an effort to produce desired traits such as higher yield or drought tolerance.
GE has been hailed by some as an indispensable tool for solving the world s food problems, and denounced by others as an example of human overreaching fraught with unknown, potentially catastrophic dangers. UCS experts analyze the applications of genetic engineering in agriculture—particularly in comparison to other options—and offer practical recommendations based on that analysis.
Benefits of GE: Promise vs. Performance
Supporters of GE in agriculture point to a multitude of potential benefits of engineered crops, including increased yield, tolerance of drought, reduced pesticide use, more efficient use of fertilizers, and ability to produce drugs or other useful chemicals. UCS analysis shows that actual benefits have often fallen far short of expectations.
Health and Environmental Risks
While the risks of genetic engineering have sometimes been exaggerated or misrepresented, GE crops do have the potential to cause a variety of health problems and environmental impacts. For instance, they may produce new allergens and toxins, spread harmful traits to weeds and non-GE crops, or harm animals that consume them.
At least one major environmental impact of genetic engineering has already reached critical proportions: overuse of herbicide-tolerant GE crops has spurred an increase in herbicide use and an epidemic of herbicide-resistant "superweeds," which will lead to even more herbicide use.
How likely are other harmful GE impacts to occur? This is a difficult question to answer. Each crop-gene combination poses its own set of risks. While risk assessments are conducted as part of GE product approval, the data are generally supplied by the company seeking approval, and GE companies use their patent rights to exercise tight control over research on their products. In short, there is a lot we don't know about the risks of GE—which is no reason for panic, but a good reason for caution.
What Other Choices Do We Have?
All technologies have risks and shortcomings, so critics must always address the question: what are the alternatives? In the case of GE, there are two main answers: crop breeding, which produces traits through the organism s reproductive process; and agroecological farm management, which seeks to make the most of a plant s existing traits by optimizing its growing environment. These approaches are generally far less expensive than GE, and often more effective.
The biotechnology industry has acknowledged the value of breeding as a complement to GE. But at the same time, the industry has used its formidable marketing and lobbying resources to ensure that its products—and the industrial methods those products are designed to support—continue to dominat ...
Gene therapy advanced treatments for a new era aranca special reportAranca
Aranca's Report on Gene Therapy - a promising tool for Cancer, Parkinson's, HIV, severe combined immuno-deficiencies, hemophilia etc. In this report, you will discover the challenges associated with Gene Therapy as well as its expected future.
Gene therapy involves the insertion of a functioning gene into cells to correct a cellular dysfunction
KEY WORDS : GENETICS, MUTATION , GENETIC ENGINEERING.
Forum on Personalized Medicine: Challenges for the next decadeJoaquin Dopazo
Bioinformatics and Big Data in the era of Personalized Medicine
10th Anniversary Instituto Roche Forum on Personalized Medicine: Challenges for the next decade.
Santiago de Compostela (Spain), September 25th 2014
January 26, 2018
In the United States, two major federal laws apply to vertebrate animals used in laboratory research. The first of these two statutes, the Animal Welfare Act (AWA, under the US Department of Agriculture), celebrated its fiftieth anniversary in 2016. The second statute, the Health Research Extension Act of 1985 (also referred to as the Public Health Services Act, or PHS Act), which is similar to the AWA, applies specifically to work funded by the US Public Health Service (i.e., agencies under the Department of Health and Human Services). Understanding laboratory animal law is necessary and fundamental for all researchers relying on results from animal research, laboratory animal veterinarians, institutional officials, Institutional Animal Care and Use Committee (IACUC) members and veterinarians in training. They require familiarity with both the scope and particulars of these laws. Different parties interested in or impacted by laboratory animal laws can have significantly different perspectives about the scope or efficiency of the regulations or their implementation.
The Roundtable on Science and Welfare in Laboratory Animal Use of the Institute for Laboratory Animal Research, the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics, and the Animal Law and Policy Program of Harvard Law School convened this pre-workshop webcast and a workshop to discuss the future of federal laboratory animal law in the United States.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/future-directions-for-laboratory-animal-law-in-the-united-states
Gene therapy is a new tool used in combating different diseases. The majority of gene therapy clinical trials are focused on cancer and so it was no coincidence that the first commercial treatment in 2003 was for neoplasia. Currently there are a wide variety of gene therapy proposals involving a large number of anti tumour molecular mechanisms that will conceivably pave the way for highly effective a treatment options. Despite the significant advances that how been made in gene therapy in the fight against cancer, its efficacy,safety and commercial availability are still limited. Ms. Chetana D. Patil | Ms. Siddhi Chavan | Mr. Ritesh Kadam "Gene Therapy for Cancer Treatment" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-5 , August 2019, URL: https://www.ijtsrd.com/papers/ijtsrd26537.pdfPaper URL: https://www.ijtsrd.com/pharmacy/biotechnology-/26537/gene-therapy-for-cancer-treatment/ms-chetana-d-patil
Nutrigenomics is the science that examines the response of individuals to food compounds using post-genomic and related technologies (e.g. genomics, transcriptomics, proteomics, metabol/nomic etc.). The long-term aim of nutrigenomics is to understand how the whole body responds to real foods using an integrated approach termed 'systems biology'. The huge advantage in this approach is that the studies can examine people (i.e. populations, sub-populations - based on genes or disease - and individuals), food, life-stage and life-style without preconceived ideas.
Steve Rozen's keynote talk at IEEE CIBCB 2016
Big Genome Data Sheds Light on Cancer Causes
Steven G. Rozen, PhD
Professor, Cancer & Stem Cell Programme, Duke-NUS Medical School, Singapore
Director, Duke-NUS Centre for Computational Biology
The last eight years have see a revolution in the availability of DNA sequencing data. This revolution has been driven by costs that have plummeted from US$ 10 million per human genome in 2008 to US $1,200 today. Abundant sequencing data brings with it a previously unimaginable range of research possibilities in all areas of biomedical research. Naturally, these research possibilities make heavy demands on computation and data storage, because costs of sequencing are falling much faster than Moore's law. In this talk I will present a high level overview of these computational demands. I will then go into detail on a few of the cancer-related big data projects my lab is working on. One of these is "mutation signature analysis", which has important applications in cancer prevention and epidemiology and in research into the fundamental processes by which cancers arise. One example of the importance of this approach is the recent finding that a highly mutagenic herbal remedy is implicated in many more geographical regions and types of cancer than suspected a few years ago.
Gene is the basic physical unit of inheritance that passed information from parents to offspring. Genes are arranged, one after another, on structure called chromosome.
A gene is region of DNA that encodes function and chromosome consist of long DNA strands containing many genes.
A human chromosome can have up to 500 million base pair of DNA with thousands of genes.
Technique responsible for correcting the defective genes responsible for disease development is called Gene Therapy
Final presentation for BIOL405, NSC, Spring 2014. Presented by Kevin Hugins and Duy-Khiem Chanh Pham. This presentation addressed the use of Chimeric Antigen Receptors for gene therapy for cancer. Gene therapy was first conceptualized to alter debilitating fates of genetic diseases. Gene therapy technology can help introduce new functional DNA to replace mutated genes. The idea first arose in 1972 when Friedmann and Roblin authored a paper, “Gene therapy for human genetic disease?”, demonstrating that exogenous DNA can be taken up by mammalian cells (1). They proposed that the same procedure could be done on humans to correct genetic defects by introducing therapeutic DNA. Currently, genetic modification of T lymphocytes has been the major area of research for treating malignant tumors. This technique seeks to create chimeric antigen receptor (CAR) in T cells by genetically modifying them in vitro and reintroduce them back into blood circulation. The T cells are unique to every patient and the chimeric antigen receptors are unique to the tumor that it is targeting.
Crowdsourcing applied to knowledge management in translational research: the ...SC CTSI at USC and CHLA
Date: November 8th, 2018
Speaker: Andrew Su, PhD, Professor, Department of Integrative, Structural and Computational Biology, The Scripps Research Institute
Overview: Crowdsourcing involves the engagement of large communities of individuals to collaboratively accomplish tasks at massive scale. These tasks could be online or offline, paid or for free. But how can crowdsourcing science help your research? This webinar will describe two crowdsourcing projects for translational research, both of which aim to better organize biomedical information so that it can be more easily accessed, integrated, and queried:
First, the goal of the Gene Wiki project is to create a community-maintained knowledge base of all relationships between biological entities, including genes, diseases, drugs, pathways, and variants. This project draws on the collective efforts of informatics researchers from a wide range of disciplines, including bioinformatics, cheminformatics, and medical informatics.
Second, the Mark2Cure project partners with the citizen scientist community to extract structured content from biomedical abstracts with an emphasis on rare disease. Although citizen scientists do not have any specialized expertise, after receiving proper training, Mark2Cure has shown that in aggregate they perform bio-curation at an accuracy comparable to professional scientists.
Genetic Engineering in AgricultureFew topics in agriculture are .docxhanneloremccaffery
Genetic Engineering in Agriculture
Few topics in agriculture are more polarizing than genetic engineering (GE), the process of manipulating an organism s genetic material—usually using genes from other species—in an effort to produce desired traits such as higher yield or drought tolerance.
GE has been hailed by some as an indispensable tool for solving the world s food problems, and denounced by others as an example of human overreaching fraught with unknown, potentially catastrophic dangers. UCS experts analyze the applications of genetic engineering in agriculture—particularly in comparison to other options—and offer practical recommendations based on that analysis.
Benefits of GE: Promise vs. Performance
Supporters of GE in agriculture point to a multitude of potential benefits of engineered crops, including increased yield, tolerance of drought, reduced pesticide use, more efficient use of fertilizers, and ability to produce drugs or other useful chemicals. UCS analysis shows that actual benefits have often fallen far short of expectations.
Health and Environmental Risks
While the risks of genetic engineering have sometimes been exaggerated or misrepresented, GE crops do have the potential to cause a variety of health problems and environmental impacts. For instance, they may produce new allergens and toxins, spread harmful traits to weeds and non-GE crops, or harm animals that consume them.
At least one major environmental impact of genetic engineering has already reached critical proportions: overuse of herbicide-tolerant GE crops has spurred an increase in herbicide use and an epidemic of herbicide-resistant "superweeds," which will lead to even more herbicide use.
How likely are other harmful GE impacts to occur? This is a difficult question to answer. Each crop-gene combination poses its own set of risks. While risk assessments are conducted as part of GE product approval, the data are generally supplied by the company seeking approval, and GE companies use their patent rights to exercise tight control over research on their products. In short, there is a lot we don't know about the risks of GE—which is no reason for panic, but a good reason for caution.
What Other Choices Do We Have?
All technologies have risks and shortcomings, so critics must always address the question: what are the alternatives? In the case of GE, there are two main answers: crop breeding, which produces traits through the organism s reproductive process; and agroecological farm management, which seeks to make the most of a plant s existing traits by optimizing its growing environment. These approaches are generally far less expensive than GE, and often more effective.
The biotechnology industry has acknowledged the value of breeding as a complement to GE. But at the same time, the industry has used its formidable marketing and lobbying resources to ensure that its products—and the industrial methods those products are designed to support—continue to dominat ...
Biotechnology, the application of scientific knowledge and techniques to living organisms, has been at the forefront of numerous breakthroughs in the fields
Raising Awareness and Discovering the Dirt 12345 .docxrobert345678
Raising Awareness and Discovering the Dirt
12345 Canyon Dr., Northridge, CA 91344 (818) 555-9089 (818) 555-9222 Radd.com
RADD
What role can the FDA play in regulating GMO
products?
This brief is intended for the United States Food and Drug Administration (FDA) and is
presented on behalf of Raising Awareness and Discovering the Dirt (RADD). RADD is a non-profit
organization committed to promoting the wellness of the environment.
Since the earlier 1990s, commercialization of Genetic Modified Organisms (GMOs) has spread
throughout the U.S. The FDA has promoted a program of self-regulation among the biotech crop and
food developers (www.fda.gov). Many of the biotech food and crop developers’ primary interest is the
development of high-yielding products. For example, Monsanto, a biotech food and crop developer’s
director of corporate communications, Philip Angell was quoted saying; “Monsanto should not have to
vouchsafe the safety of biotech food. Our interest is in selling as much of it as possible. Assuring its
safety is the FDA’s job,” (Antoniou, Robinson, & Fagan, 2012, p. 23).
Finally, research and Monsanto’s own feeding trials revealed health-effects and suggest that
more suitable options are needed to maintain the safety of consumers and the environment. Therefore,
RADD is committed to working with the FDA in creating programs that will ensure the safety of
environment and the use of GMOs.
Statement of Issue:
In order to promote awareness and ultimately protect the health of consumers, the FDA has the
ability to regulate GMOs by establishing new guidelines. There is a growing body of evidence that
connects GMOs with health problems, environmental damage, and violation of rights of farmers and
consumers. Studies show a correlation between GMOs and health problems such as production of new
allergens increased toxicity, decreased nutrition, and antibiotic resistance (Bernstein et al., 2003).
Additionally, since the emergence of GMO crops, there has been an increase in the amount of
agriculture changes. Such changes include the development of “massive weeds” and “super bugs,” both
requiring an increased dosage of toxins to rid of these unwanted, overgrown organisms. In return,
consumers are now ingesting these increased dosages of toxins.
Background:
Ultimately, the only beneficiaries of products containing GMOs are its producers, such as,
Monsanto, rather than consumers. Monsanto makes an abundant amount of profit on their GMO
products as they have scientifically modified crops, allowing them to have faster results. The “proposed”
purpose of GMOs was to increase yield and enhance nutritional value, while also lowering the use of
pesticides. (www.nongmoproject.org, 2013). Indeed, the use of GMOs increase yield, but studies show
that GMO products hold no nutritional value and rather, by decreasing the use of pesticides, there has
been an increase .
The International Journal of Engineering and Science (The IJES)theijes
The International Journal of Engineering & Science is aimed at providing a platform for researchers, engineers, scientists, or educators to publish their original research results, to exchange new ideas, to disseminate information in innovative designs, engineering experiences and technological skills. It is also the Journal's objective to promote engineering and technology education. All papers submitted to the Journal will be blind peer-reviewed. Only original articles will be published.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
1. Legal trends in
Genetic modification
(GMOs)
The work done from Definition to
Recombinant DNA technology is done
by:
Mahnoor Javaid
Roll No. : 16119
And from Cons and Pons to conclusion
is done by:
Sidra Khalil
Roll No. : 16118
BS(hon’s) Bioinformatics
6th semester, evening
Department of biotechnology and
bioinformatics
G.C.U.F
2. Definition
Genetic engineering is a new technology involving gene manipulation by humans.
It is defined as a set of techniques that the desired genes are obtained in the
laboratory, after which they are transferred to another bodyof the same species or
different species for the production of biological structures anticipated new genetic
properties.
There are following some points which will help us more to understand that
conceptmore easily an elaborately.
A bit introduction:
The extent to which activities are carried out in recent years the genetic
modification of plants of different varieties gave rise to different reactions from the
countries of the world. Largest growers of genetically modified organisms (GMOs)
strongly supportthe benefits of new types of crops, but the opposite, other
countries of the world contest usefulness of GMOs, citing several disadvantages
rather than from the last two decades as a result of using genetically modified
organisms in food. European Union expressed its disagreement with the large scale
production of GMOs, maintaining long a moratorium on GM products. As a
solution to have a minimum issue of GMO control, is called the precautionary
principle as the basis for jurisprudence and legal basis in the activity.
1.Current trends which are used today
Genomic data integrated into clinicalworkflows.
Maternity genetic screening.
New data streams.
Non invasive cancerscreening.
Pharmacogenomics.
Transgenic plants.
Recombinant DNA technology.
2. Principles.
3. Importance.
3. Legal Trends in Genetic Modification
The exciting realm of genetic research could prove revolutionary as researchers
begin to scratch the surface of its implications for health care. Genetic modification
allows medical professionals to affect patients at a minute level. Initiatives never
before possible could become conceivable and, with time, perhaps even a part of
standard procedure. However with new advancements and abilities, they also come
with often complex questions of ethicality and legality. As health care trends
continue to extend into genetic modification, the legal and ethical uncertainties of
such development must be given careful consideration.
Legal and Ethical Ramifications of Genetic Modification
According to the Library of Congress, no federal legislations yet exist that address Genetically
Modified Organisms (GMO’s). The current stance of the American government is that products
should be regulated in their complete and usable form, not during their production. While this
premise has been, at this point, only applied to items such as genetically modified livestock and
agricultural food products, a future that includes much more genetic modification in realms that
extend beyond food is close at hand. American legislative bodies must prepare themselves to
deal with cases that involve much more genetic modification, specifically within health care.
In addition to legal statutes, fundamental ethical questions will need to be addressed as genetic
modification becomes more widely utilized. Issues of ownership, prioritization, employment,
health insurance, citizenship and basic human rights could become muddled and require
clarification when essential changes to a person or elements of that person are made.
Genetic Modification Trends
Branches of genetic modification, though still in their infancy, are beginning to
take shape and are already allowing trends to form that will continue to strengthen
as time goes on. Here are a few trends emerging within the field of genetic
modification:
● Genomic data integrated into clinicalworkflows.
Still a nascent practice, utilizing genomic data when making treatment decisions
for any patient is quickly becoming a sought-after ability because of its heightened
accuracy and ability to avoid procedures that could actually harm the patient or
cause an undesired result. An example of this in play is the utilization of checking
for certain genes in female patients before deciding whether or not mastectomies
are necessary in the treatment of possible or confirmed breast cancer. Certain
4. genes, when mutated, can make patients much more susceptible to breast cancer
than if those genes exist in their normal form within the patient. Checking the
condition of those genes in a patient can provide sharp clarity for an attending
physician as they consider treatment options.
● Maternity genetic screening.
It is currently possible to have an unborn child screened for select chromosomal
conditions including Down Syndrome by using non-invasive techniques to explore
the baby’s genome. Medical professionals predict that having a baby’s entire
genome sequenced before birth could becomecommonplace in as early as the
coming one to two decades. This information could provide insights that might
influence what drugs are administered, what weaknesses or predispositions the
parents should watch for and more.
● New data streams.
Genetic data can not only influence the care of an individual patient, but when
combined and synthesized with the information gained from an entire population
of patients, could allow for unprecedented understanding and advancements.
Access to the amount of data that genetic sequencing affords could drastically
affect the way we look at public health care.
● Non invasive cancerscreening.
Early studies using a process called DNA liquid biopsy testing are being conducted
to test the viability of using genetic DNA analysis on drawn blood to indicate the
presence of cancer. The current process fordetermining the existence of cancerous
cells and tumors requires medical imaging procedures ortissue biopsies, both of
which require significant time and resources. However, with the new procedure
that is currently undergoing analysis, it is conceivable that a patient could be
screened for cancer via a simple draw of blood.
● Pharmacogenomics.
This emerging field combines pharmacology (or the study and science of drugs)
witsth genomics (the study of the human gene). By studying the varying effects of
drugs on patients based on the differences that exist within each person’s
individual genome, medical professionals can better predict what effects a drug
might have on a given patient before administering it. This can help increase their
effectiveness and reduce the number of negative and sometimes harmful or even
lethal effects an inappropriate drug can induce.
Genetic modification and its escalating place in today’s health care trends could
soonmake unprecedented changes to health care, preventative medicine,
pharmacology and population health. However, its fundamental implications and
unexplored ethical and legal territories make it an exciting and daunting landscape
for the future of medicine.
5. Now here we will discuss GMOs. Which is described below.
Transgenic plants
were conducted under laboratory conditions by insertion of bacterial antibiotic
resistance genes in tobacco and a gene from beans sunflower currently the most
important transgenic crops are soybean, maize, tobacco,cotton, canola, tomatoes
and potatoes. This allows genetic genius today even create artificial genes or
genetic modification of the same species, by inaction, modifying or adding any of
its own genes.
Recombinant DNA technology
By pathogenic organisms which once escaped into the wild (intentionally or
willfully) may
Cause unknown diseases or catastrophic ecological imbalances. for example,
expects to convert cellulose into liquid and gaseous fuels, to imagine what it would
mean for the planet green shell Escape into the environment of genetically
modified organisms for cellulose Degradation.
Here are some of the Cons and Pons of GMOs
Cons:
Advantages of genetically modified organisms According to a report by FAO
(2001) (estate and Agriculture Organization of the United Nations) practical
potential benefits of biotechnology are: improving the nutritional value of foods
high consumption, reducing environmental impact, improving efficiency in
fisheries, increased absorptionfor animal feed of chemicals, tolerance to poor
environmental conditions.
Pons:
Here are some of the disadvantages of genetically modified production:
Excessive breeding, which would make a genetically modified plant invader of
agro ecosystems, Modifying biochemicalcycles (nitrogen and carbon cycles)
Inappropriate transfer of transgenes to other plants, Cultivated or wild flora,
6. following the occurrence of a "gene flow" through pollen carried by wind or
insects negative influence on the interaction between species (prey-predator
relationships, parasitism) and unanticipated direct impact on non-target species
(e.g., reduction of food resources or the habitat upon which the survival of other
organisms) due to changes in population dynamics of transmission of a character
unintentionally modified transgenic plants related species of wild flora.
AN ENVIRONMENTAL LAW PROBLEM UNDER DEVELOPED
GENETICALLY MODIFIED ORGANISMS. FRANCE MODEL
Genetic modification of microorganism’s activity paved the way explicit
integration of the precautionary principle among legal sources. In this respect, the
French Council of State has been notified of appeals directed against a decision of
the Minister of Agriculture, who inscribed the Official Catalogue of Species 3
varieties of genetically modified corn, which makes the marketing of these seeds
formality in France. (Van Lang Agathe,2002). Before the Association Greenpeace
France, with a request to postponethe execution of the judgment, gave
administrative jurisdiction successful, while recognizing the precautionary
principle invoked directly. In fact, invoking the precautionary principle in the
version of Law in 1995, supplemented by other textual, appeared serious and
justifies the annulment of the contested judgment. Consider the consequences of
enforcement difficult to repair public health and the environment, combined with
the annulment serious way, managed to postponethe execution of a concession.
(EC S., September 25, 1998, Association Greenpeace France, Agathe Van Lang,
2002). On the merits, the State Council postponed the ECJ examination of two
issues damaging the ban by the European Directive of 23 April 1990 on the
deliberate release of GMOs, as long as the authorization procedure and marketing
is very complex. (EC S., 11 December 1998, Catherine Roche, 2006). In response,
the ECJ (ECJ) said in a judgment of 21 March 2000 that France, which has notified
authorization application to the European Courts favorable opinion, was in the case
of legal powers over which the Commission ruled favorably on file. Existence of
new information elements that allow suspecta risk to human health and the
environment, relieve Member States to give their consent. It should be noted that
the ECJ interprets this Directive with regard to GMOs by ensuring respectthe
precautionary principle, which manifests itself in the obligation to inform in case
of new items and the risks associated with GMOs and faculty for all Member
States, in this case, to limit or prohibit the sale to the territory. Finally, the State
Council was forced to validate the marketing authorization of new elements. (EC
7. S., November 22, 2000, Assoc. GreenpeaceFrance, Agathe Van Lange, 2002).
Since then,
GM has focused on litigation over the legality of municipal decisions banning
GMO crops in full field commune’s territories in order to avoid genetic pollution
that harms the development of organic agriculture and biodiversity.
The judge limited the primary role in the deliberate release of GMOs, if applicable
solution transposing segment imminent danger classified installations.
Importance and Discussion:
GMO issue is still controversial and currently there is a genuine dispute between
supporters and opponents of GMOs them. Lack of consensus surrounding the food
safety of citizens, especially in European countries are reluctant to products
containing genetically modified organisms. Insufficient information to citizens on
GMOs will only confuse them and they are more difficult choice
It is important for citizens to be informed and be given respect the rights resulting
from their consumer. According to the Cartagena Protocol, the Parties shall
promote and facilitate public awareness, education and participation in the transfer,
handling and safe use of genetically modified organisms, the conservation and
sustainable use of biological diversity,
taking into account the risks human health. Nobodycan say for sure that GMO
foods are safe for human health. Recent studies have confirmed that genetic
engineering produceunintended and unanticipated negative effects and that current
risk assessments are inadequate for predicting adverse effects of GM foods on
health.
Precautionary principle.
The precautionary principle is a fundamental principle of environmental law that
the absence of uncertainty should not prevent the adoption of measures to prevent
the risk of producing a significant and irreversible damage to the environment.
Caution requires that measures to be taken, even if no damage is not looming in the
near future. In terms of proof, the burden of carrying it reverses. She is now the
one who claims that his work has or will have no impact until the accumulation of
scientific data to prove that there is a cause and effect relationship between
development activities and environmental degradation.
This law may require in this case:
cautious progress until a trial can be considered "harmless";
8. regular progress until they are found evidence of innocence;
or no progress until it was done intensive research process was proposedand
demonstrated his innocence.
Conclusion:
Insufficient knowledge of the use in food of genetically modified plant varieties
gave way to an approachbased on the precautionary principle. But this time the
precautionary approach, is displeasing big producers of genetically modified
organisms.
Earthy living Regarding environmental law genetically modified organisms, it is
noteworthy that it is still at an early stage, because of the novelty that it has this
problem. Judges in resolving pending cases began to appeal to the precautionary
principle, but not often enough that they have formed a strong environmental law.
Principle as a rule of conductestablished considering 74 the probability and
severity of ecological damage, before taking any decision.
There is still a long way to go before everyone will understand that precaution,
complete prevention can become even a lifestyle that they must be raised to the
rank of general rules, universal, applicable in any situation, thus implicitly policy
of protection, conservation and improvement of the environment.